Global Sterility Indicators Market to Reach $1.4 Billion by 2027
Abstract: - Global Sterility Indicators Market to Reach $1. 4 Billion by 2027. - Amid the COVID-19 crisis, the global market for Sterility Indicators estimated at US$727. 4 Million in the year 2020, is projected to reach a revised size of US$1.
New York, May 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Sterility Indicators Industry" - https://www.reportlinker.com/p06033009/?utm_source=GNW
4 Billion by 2027, growing at aCAGR of 9.5% over the period 2020-2027. Biological, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$776.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemical segment is readjusted to a revised 11% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $196.8 Million, While China is Forecast to Grow at 12.6% CAGR
- The Sterility Indicators market in the U.S. is estimated at US$196.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$285 Million by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.
- Select Competitors (Total 40 Featured) -
3m Company
Anderson Products, Inc
Cantel Medical Corporation
Cardinal Health
Getinge Ab
gke-GmbH
Hu-Friedy Mfg. Co., LLC
Matachana Group
Mesa Laboratories
PMS
Propper Manufacturing Co., Inc
Steris plc
Read the full report: https://www.reportlinker.com/p06033009/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Sterility
Indicators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Sterility Indicators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Sterility Indicators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Biological by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Biological by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Biological by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Chemical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Chemical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Chemical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Clinical
Laboratories / Research Centers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Clinical Laboratories /
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Clinical Laboratories /
Research Centers by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 13: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Pharmaceutical
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Pharmaceutical Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Pharmaceutical
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 22: World Current & Future Analysis for Medical Device
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Medical Device Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Medical Device
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 25: World Current & Future Analysis for Heat by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Heat by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Heat by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Low Temperature
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Low Temperature by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Low Temperature by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Filtration by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 32: World Historic Review for Filtration by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 33: World 15-Year Perspective for Filtration by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 34: World Current & Future Analysis for Other
Sterilization Methods by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 35: World Historic Review for Other Sterilization Methods
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 36: World 15-Year Perspective for Other Sterilization
Methods by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
III. MARKET ANALYSIS
UNITED STATES
Table 37: USA Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 38: USA Historic Review for Sterility Indicators by Type -
Biological and Chemical Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 39: USA 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027
Table 40: USA Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 41: USA Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 42: USA 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 43: USA Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 44: USA Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 45: USA 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
CANADA
Table 46: Canada Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 47: Canada Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 48: Canada 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 49: Canada Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 50: Canada Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 51: Canada 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 52: Canada Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 53: Canada Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 54: Canada 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
JAPAN
Table 55: Japan Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 56: Japan Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 57: Japan 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027
Table 58: Japan Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 59: Japan Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 60: Japan 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 61: Japan Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 62: Japan Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 63: Japan 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
CHINA
Table 64: China Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 65: China Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 66: China 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027
Table 67: China Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 68: China Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: China 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 70: China Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 71: China Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 72: China 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
EUROPE
Table 73: Europe Current & Future Analysis for Sterility
Indicators by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 74: Europe Historic Review for Sterility Indicators by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Sterility Indicators
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 76: Europe Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 77: Europe Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 78: Europe 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 79: Europe Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 80: Europe Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 83: Europe Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 84: Europe 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
FRANCE
Table 85: France Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 86: France Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 87: France 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 88: France Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 89: France Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 90: France 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 91: France Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 92: France Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 93: France 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
GERMANY
Table 94: Germany Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 95: Germany Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 96: Germany 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 97: Germany Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 98: Germany Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 99: Germany 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 100: Germany Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 101: Germany Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 102: Germany 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
ITALY
Table 103: Italy Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 104: Italy Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 105: Italy 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 106: Italy Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 107: Italy Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 108: Italy 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 109: Italy Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 110: Italy Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 111: Italy 15-Year Perspective for Sterility Indicators
by Sterilization Method - Percentage Breakdown of Value Sales
for Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 112: UK Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 113: UK Historic Review for Sterility Indicators by Type -
Biological and Chemical Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 114: UK 15-Year Perspective for Sterility Indicators by
Type - Percentage Breakdown of Value Sales for Biological and
Chemical for the Years 2012, 2020 & 2027
Table 115: UK Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 116: UK Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 117: UK 15-Year Perspective for Sterility Indicators by
End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 118: UK Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 119: UK Historic Review for Sterility Indicators by
Sterilization Method - Heat, Low Temperature, Filtration and
Other Sterilization Methods Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 120: UK 15-Year Perspective for Sterility Indicators by
Sterilization Method - Percentage Breakdown of Value Sales for
Heat, Low Temperature, Filtration and Other Sterilization
Methods for the Years 2012, 2020 & 2027
SPAIN
Table 121: Spain Current & Future Analysis for Sterility
Indicators by Type - Biological and Chemical - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 122: Spain Historic Review for Sterility Indicators by
Type - Biological and Chemical Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 123: Spain 15-Year Perspective for Sterility Indicators
by Type - Percentage Breakdown of Value Sales for Biological
and Chemical for the Years 2012, 2020 & 2027
Table 124: Spain Current & Future Analysis for Sterility
Indicators by End-Use - Clinical Laboratories / Research
Centers, Other End-Uses, Hospitals, Pharmaceutical Companies
and Medical Device Companies - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 125: Spain Historic Review for Sterility Indicators by
End-Use - Clinical Laboratories / Research Centers, Other
End-Uses, Hospitals, Pharmaceutical Companies and Medical
Device Companies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 126: Spain 15-Year Perspective for Sterility Indicators
by End-Use - Percentage Breakdown of Value Sales for Clinical
Laboratories / Research Centers, Other End-Uses, Hospitals,
Pharmaceutical Companies and Medical Device Companies for the
Years 2012, 2020 & 2027
Table 127: Spain Current & Future Analysis for Sterility
Indicators by Sterilization Method - Heat, Low Temperature,
Filtration and Other Sterilization Methods - Independent
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033009/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001